Citation: Dp. Tsakonas et al., CHANGES IN MATERNAL PLASMA MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS DURING NORMAL-PREGNANCY, Clinical and laboratory haematology, 17(1), 1995, pp. 57-59
Citation: Dp. Tsakonas et al., MYELOPEROXIDASE ACTIVITY AND NUCLEAR SEGMENTATION OF MATERNAL NEUTROPHILS DURING NORMAL-PREGNANCY, Clinical and laboratory haematology, 16(4), 1994, pp. 337-342
Citation: Ap. Jewell et al., SERUM MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF) LEVELS CORRELATE WITH CLINICAL-RESPONSE TO INTERFERON-ALPHA IN PATIENTS WITH EARLY-STAGEB-CLL, British Journal of Haematology, 86(2), 1994, pp. 441-443
Citation: Cp. Tsakona et al., DOES TREATMENT WITH HEMATOPOIETIC GROWTH-FACTORS AFFECT THE INCIDENCEOF BACTEREMIA IN ADULT LYMPHOMA TRANSPLANT RECIPIENTS, Bone marrow transplantation, 11(6), 1993, pp. 433-436
Citation: Cp. Tsakona et al., MEAN MYELOPEROXIDASE INDEX IN LYMPHOMA TRANSPLANTS RECEIVING RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Bone marrow transplantation, 11(4), 1993, pp. 345-346
Authors:
MCSWEENEY EN
GILES FJ
WORMAN CP
JEWEL AP
TSAKONA CP
HOFFBRAND AV
MEHTA AB
NEWLAND AC
CAWLEY JC
GALVANI D
SINGER CRJ
GRANT IR
NORFOLK DR
GOLDSTONE AH
Citation: En. Mcsweeney et al., RECOMBINANT INTERFERON-ALFA 2A IN THE TREATMENT OF PATIENTS WITH EARLY STAGE-B CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 85(1), 1993, pp. 77-83
Authors:
TSAKONA CP
WORMAN CP
MCSWEENEY E
JEWELL A
GOLDSTONE AH
Citation: Cp. Tsakona et al., PLASMA M-CSF LEVELS IN AML AS A MARKER OF DISEASE-ACTIVITY AND RESPONSE TO TREATMENT WITH ALPHA-2A INTERFERON, British Journal of Haematology, 84, 1993, pp. 33-33
Authors:
TSAKONA CP
MITSOU J
MCGROUTHER DA
CROWE R
GOLDSTONE AH
WORMAN CP
Citation: Cp. Tsakona et al., CD8-SPECIFIC SERINE ESTERASE ARE EFFECTORS OF REJECTION OF COMPLETELYMISMATCHED SKIN ALLOGRAFTS IN THE RAT( LYMPHOCYTES BEARING CYTOPLASMIC BLT), British Journal of Haematology, 84, 1993, pp. 54-54
Authors:
MCSWEENEY EN
WORMAN CP
TSAKONA CP
JEWEL AP
HOFFBRAND AV
MILLIGAN DW
BURNETT AK
LEWIS ML
GOLDSTONE AH
Citation: En. Mcsweeney et al., LOW-DOSE RECOMBINANT ALPHA-2-A-INTERFERON - A FEASIBLE MAINTENANCE THERAPY IN ACUTE MYELOID-LEUKEMIA IN THE OLDER PATIENT, Acta haematologica, 89(1), 1993, pp. 1-5